/Companies

F1 Oncology

West Palm Beach, US · Founded 2015 · Delaware corporation · 26 employees on LinkedIn

Find your way into F1 Oncology

218 people in our graph share verified history with the F1 Oncology team — schools, employers, funds. One of them is your warm intro.

Jonathan Leffunlockedknows Gregory Frost · together at Halozyme Therapeutics, Inc. (overlapped)
×6knows the team · via Halozyme Therapeutics, Inc.
×5knows the team · via Intrexon Corporation

Founders & leadership

GF
Gregory FrostChairman & CEOGregory Frost is an executive officer and director at EXUMA Biotechnology, a clinical-stage biotech company developing adoptive cellular therapy candidates for cancer treatment across research facilities in Florida, California, the Cayman Islands, Hong Kong, and China.
RY
Richard YanPrincipal Accounting Officer
JS
Jay ShortNamed on SEC filing

Board

DR
David RamsayBoard director
DF
Daniel FlynnBoard director
HH
Houston HolmesBoard director
FM
Frank McCormickBoard director

Reported raises · per SEC filings

Form D private placements

$133M disclosed across 3 of 4 rounds · 2016–2026

▶$70MraisedAug 2026 · 26 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Gregory FrostExecutive Officer, Director
  • David RamsayDirector
  • Daniel FlynnDirector
  • Houston HolmesDirector
  • Frank McCormickDirector
  • Richard YanExecutive Officer
Offering amount
$70M
Amount sold
$70M
First sale
May 2026
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$18.9MraisedApr 2020 · 12 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Scott SegalDirector
  • David RamsayDirector
  • Gregory FrostExecutive Officer, Director
  • Frank McCormickDirector
Offering amount
$18.9M
Amount sold
$18.9M
First sale
Dec 2019
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$44MraisedFeb 2017 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jay ShortDirector
  • David RamsayDirector
  • Gregory FrostExecutive Officer, Director
Offering amount
$94M
Amount sold
$44M
First sale
Jun 2016
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has F1 Oncology raised?
F1 Oncology has disclosed $133M raised across 3 of its 4 known rounds.
Where is F1 Oncology headquartered?
F1 Oncology is headquartered in West Palm Beach, US.